An expanded clinical trial that tested an experimental stem cell treatment for blinding cornea injuries found the treatment was feasible and safe in 14 patients who were treated and followed for 18 ...

CALEC could become one of the first major examples of stem cell therapy's potential to repair once-unfixable injuries. Reading time 3 minutes Scientists at Mass Eye and Ear are winners of the 2025 ...

Results from a phase 1/2 clinical trial of a novel stem cell treatment for cornea injuries found 14 patients treated and tracked for 18 months had a more than 90% success rate at restoring the ...

CALEC trial principal investigator Ula Jurkunas, MD, associate director of the Cornea Service at Mass Eye and Ear and professor of Ophthalmology at Harvard Medical School, in her lab at Mass Eye and ...